Stock Analysis
- Sweden
- /
- Medical Equipment
- /
- OM:SUS
Sectra And Two More Swedish Exchange Growth Companies With High Insider Ownership
Reviewed by Simply Wall St
As global markets navigate through a mix of challenges and opportunities, with recent shifts favoring value over growth stocks in some regions, the Swedish market presents its own set of dynamics. In this context, companies like Sectra that combine robust growth prospects with high insider ownership may offer a compelling narrative for investors looking to align with closely held leadership visions amid broader market fluctuations.
Top 10 Growth Companies With High Insider Ownership In Sweden
Name | Insider Ownership | Earnings Growth |
CTT Systems (OM:CTT) | 16.9% | 24.8% |
Biovica International (OM:BIOVIC B) | 18.7% | 73.8% |
Magle Chemoswed Holding (OM:MAGLE) | 14.9% | 72.2% |
Sileon (OM:SILEON) | 20.3% | 109.3% |
KebNi (OM:KEBNI B) | 37.8% | 90.4% |
Yubico (OM:YUBICO) | 37.5% | 43.8% |
BioArctic (OM:BIOA B) | 34% | 50.9% |
Calliditas Therapeutics (OM:CALTX) | 11.6% | 52.9% |
edyoutec (NGM:EDYOU) | 14.6% | 63.1% |
SaveLend Group (OM:YIELD) | 23.3% | 103.4% |
Let's take a closer look at a couple of our picks from the screened companies.
Sectra (OM:SECT B)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Sectra AB (publ) operates in the medical IT and cybersecurity sectors across Sweden, the United Kingdom, the Netherlands, and other parts of Europe, with a market capitalization of approximately SEK 47.09 billion.
Operations: The company's revenue is primarily generated from its Imaging IT Solutions and Secure Communications segments, which respectively contributed SEK 2.55 billion and SEK 367.35 million.
Insider Ownership: 30.3%
Revenue Growth Forecast: 14.7% p.a.
Sectra, a Swedish company with high insider ownership, has demonstrated robust growth with its recent expansion into cloud services and genomic diagnostics. The firm reported a significant year-over-year sales increase to SEK 914.45 million in Q4 2024, reflecting strong operational execution. Additionally, Sectra's pioneering cloud-based solutions in Belgium and innovative genomic IT module in the US highlight its strategic focus on enhancing healthcare efficiency and precision medicine. Despite this progress, revenue growth projections remain below the high-growth threshold of 20% per year.
- Click to explore a detailed breakdown of our findings in Sectra's earnings growth report.
- According our valuation report, there's an indication that Sectra's share price might be on the expensive side.
Surgical Science Sweden (OM:SUS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Surgical Science Sweden AB, headquartered in Europe, specializes in developing and marketing virtual reality simulators for evidence-based medical training across multiple continents, with a market capitalization of approximately SEK 6.81 billion.
Operations: The company generates revenue primarily through two segments: Industry/OEM, which brought in SEK 387.52 million, and Educational Products, contributing SEK 454.50 million.
Insider Ownership: 26.6%
Revenue Growth Forecast: 17.2% p.a.
Surgical Science Sweden, with substantial insider ownership, is poised for notable growth with earnings expected to rise by 27% annually, outpacing the Swedish market's 15.2%. However, its revenue growth at 17.2% yearly lags behind the high-growth benchmark of 20%, and a forecasted Return on Equity of just 6.2% suggests modest future profitability. The recent appointment of Tom Englund as CEO could inject new vigor into the company’s strategy given his track record in scaling high-tech firms.
- Navigate through the intricacies of Surgical Science Sweden with our comprehensive analyst estimates report here.
- According our valuation report, there's an indication that Surgical Science Sweden's share price might be on the cheaper side.
Yubico (OM:YUBICO)
Simply Wall St Growth Rating: ★★★★★★
Overview: Yubico AB specializes in providing authentication solutions for computers, networks, and online services, with a market capitalization of SEK 23.34 billion.
Operations: The company generates SEK 1.93 billion from its Security Software & Services segment.
Insider Ownership: 37.5%
Revenue Growth Forecast: 22.9% p.a.
Yubico, a Swedish growth company with significant insider transactions, is expected to see robust revenue and earnings growth, outpacing the Swedish market significantly. Despite this promising outlook, recent insider activities show more selling than buying, and profit margins have decreased from the previous year. Additionally, Yubico's recent collaboration with Straxis on the MilSecure Mobile app for secure DOD web access underscores its strategic focus on enhancing cybersecurity solutions globally.
- Click here and access our complete growth analysis report to understand the dynamics of Yubico.
- Our expertly prepared valuation report Yubico implies its share price may be too high.
Next Steps
- Click through to start exploring the rest of the 89 Fast Growing Swedish Companies With High Insider Ownership now.
- Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Want To Explore Some Alternatives?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're helping make it simple.
Find out whether Surgical Science Sweden is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About OM:SUS
Surgical Science Sweden
Develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally.
Flawless balance sheet with reasonable growth potential.